5 May 2026 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has approved a dividend of USD1.73 per share on its outstanding common stock for the second quarter of 2026.This amount is unchang...
5 May 2026 - US life sciences company Lunai Bioworks Inc (NASDAQ:LNAI) announced on Monday the completion of a USD20m preferred equity issuance to acquire intellectual property assets from two counterparties, expanding the company's central nerv...
5 May 2026 - US biopharmaceutical company Neurocrine Biosciences Inc (Nasdaq:NBIX) on Monday announced the release of findings from a new survey revealing the significant impact of tardive dyskinesia (TD) on people's ability to work, go to schoo...
5 May 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq:ATOS) announced on Monday that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to (Z)-endoxifen for the treatment of ...
4 May 2026 - Norwegian bladder cancer company Photocure ASA (OSE: PHO) announced on Monday the publication of a new health economic methodology in The Journal of Medical Economics demonstrating that blue light cystoscopy is cost-effective compared wi...